共 50 条
- [41] Key developments in rectal cancer treatment - The Willet/Duda/Czito et al article reviewed ONCOLOGY-NEW YORK, 2007, 21 (09): : 1075 - +
- [42] Follicular lymphoma: Expanding therapeutic options - The Ganti/Bociek/Bierman et al article reviewed ONCOLOGY-NEW YORK, 2005, 19 (02): : 234 - 235
- [43] The role of irinotecan and oxaliplatin in the treatment of advanced colorectal cancer - The Khayat et al article reviewed ONCOLOGY-NEW YORK, 2001, 15 (04): : 430 - +
- [44] On the Road to Intraoperative Radiotherapy: More 'Proceed With Caution' Signs THE ASH ET AL ARTICLE REVIEWED ONCOLOGY-NEW YORK, 2013, 27 (02): : 113 - +
- [45] 'Unresectable' pancreatic cancer: Conceptual challenges - The Wisinski/Wahl/Small et al article reviewed ONCOLOGY-NEW YORK, 2007, 21 (13): : 1571 - 1572
- [46] Time to Move Beyond Clinical and Pathologic Classification of BAC THE LEVY ET AL ARTICLE REVIEWED ONCOLOGY-NEW YORK, 2010, 24 (10): : 900 - 901
- [47] Understanding Evaluation and Management of Primary Cutaneous and Systemic ALCL The Querfeld et al article reviewed ONCOLOGY-NEW YORK, 2010, 24 (07): : 594 - 594
- [48] Neoadjuvant chemotherapy for ovarian cancer - The Vergote/Van Gorp/Amant et al article reviewed ONCOLOGY-NEW YORK, 2005, 19 (12): : 1628 - +
- [49] Proton Therapy for Prostate Cancer: Show Me the CER! THE HOPPE ET AL ARTICLE REVIEWED ONCOLOGY-NEW YORK, 2011, 25 (07): : 652 - 657
- [50] Improved Understanding of Peripheral T-cell Lymphomas The Querfeld et al article reviewed ONCOLOGY-NEW YORK, 2010, 24 (07): : 587 - +